Viewing data from:

TYDEMY

ANDA

DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM | A205948 | LUPIN LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: BEYAZ(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Tydemy (2023)

Total Spending

$6K

Total Claims

Beneficiaries

Avg Cost/Unit

$2.50

Spending Trend

$3K(2019)→$5K(2020)→$6K(2021)→$6K(2022)→$6K(2023)

YoY Change:-28.0%

5yr CAGR:-15.4%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 3MG,N/A;0.03MG,N/A;0.451MG,0.451MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 12, 2017

No patent or exclusivity listings for this strength.